Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU
Sep 21, 2024
Dupixent Invest Information
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents
Sep 14, 2024
Regeneron Showcases Respiratory Treatments at ERS 2024 Congress
Aug 26, 2024
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment
Jul 4, 2024
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP
May 14, 2024